The need for a large-scale trial of fibrate therapy in diabetes: The rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481]

MLA

Barter, P., et al. “The Need for a Large-Scale Trial of Fibrate Therapy in Diabetes: The Rationale and Design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study. [ISRCTN64783481].” Cardiovascular Diabetology, vol. 3, Dec. 2004. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......1064..b06145f4aaacc25032ef66dd95207d20&authtype=sso&custid=ns315887.

APA

Barter, P., Best, J., Colman, P., d’Emden, M., Davis, T., Drury, P., Ehnholm, C., Glasziou, P., Hunt, D., Keech, A., Laakso, M., Scott, R., Simes, R., Sullivan, D., Taskinen, M.-R., Whiting, M., Ansquer, J.-C., Fraitag, B., Anderson, N., … Vanhala, M. (2004). The need for a large-scale trial of fibrate therapy in diabetes: The rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481]. Cardiovascular Diabetology, 3.

Chicago

Barter, P, J Best, P Colman, M d’Emden, T Davis, P Drury, C Ehnholm, et al. 2004. “The Need for a Large-Scale Trial of Fibrate Therapy in Diabetes: The Rationale and Design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study. [ISRCTN64783481].” Cardiovascular Diabetology 3 (December). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......1064..b06145f4aaacc25032ef66dd95207d20&authtype=sso&custid=ns315887.